Authors' response to 'aspirin dose for treatment of Kawasaki disease'
Arch Dis Child
.
2015 Mar;100(3):300-1.
doi: 10.1136/archdischild-2014-307798.
Epub 2014 Nov 25.
Authors
Despina Eleftheriou
1
,
Michael Levin
2
,
Delane Shingadia
3
,
Robert Tulloh
4
,
Nigel Klein
1
,
Paul Brogan
1
Affiliations
1
Institute of Child Health and Great Ormond Street, London.
2
Paediatric Infectious Diseases Group, Division of Medicine, Imperial College London.
3
Great Ormond Street Hospital, London.
4
Department of Paediatric Cardiology, Bristol Royal Hospital for Children, Bristol, UK.
PMID:
25425602
DOI:
10.1136/archdischild-2014-307798
No abstract available
Publication types
Letter
Comment
MeSH terms
Adrenal Cortex Hormones / therapeutic use*
Humans
Immunoglobulins, Intravenous / therapeutic use*
Mucocutaneous Lymph Node Syndrome / therapy*
Substances
Adrenal Cortex Hormones
Immunoglobulins, Intravenous